Surprisingly, IL-1β blockade increased the number of neutrophils, the second major constituent of immune clusters, that is in contrast to previous observations, where mice with NASH treated with NLRP3 inhibitors showed decreased hepatic neutrophil infiltration51. The gene discussed is IL1B; the disease is metabolic dysfunction-associated steatohepatitis.